Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211688
Company: ACCORD HLTHCARE

Products on ANDA 211688

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TACROLIMUS	TACROLIMUS	0.03%	OINTMENT;TOPICAL	Prescription	AB	No	No
TACROLIMUS	TACROLIMUS	0.1%	OINTMENT;TOPICAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 211688

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
01/31/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 211688

TACROLIMUS

OINTMENT;TOPICAL; 0.03%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
PROTOPIC	TACROLIMUS	0.03%	OINTMENT;TOPICAL	Prescription	Yes	AB	050777	LEO PHARMA AS
TACROLIMUS	TACROLIMUS	0.03%	OINTMENT;TOPICAL	Prescription	No	AB	211688	ACCORD HLTHCARE
TACROLIMUS	TACROLIMUS	0.03%	OINTMENT;TOPICAL	Prescription	No	AB	200744	FOUGERA PHARMS INC
TACROLIMUS	TACROLIMUS	0.03%	OINTMENT;TOPICAL	Prescription	No	AB	210393	GLENMARK PHARMS LTD

OINTMENT;TOPICAL; 0.1%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
PROTOPIC	TACROLIMUS	0.1%	OINTMENT;TOPICAL	Prescription	Yes	AB	050777	LEO PHARMA AS
TACROLIMUS	TACROLIMUS	0.1%	OINTMENT;TOPICAL	Prescription	No	AB	211688	ACCORD HLTHCARE
TACROLIMUS	TACROLIMUS	0.1%	OINTMENT;TOPICAL	Prescription	No	AB	212387	ENCUBE
TACROLIMUS	TACROLIMUS	0.1%	OINTMENT;TOPICAL	Prescription	No	AB	200744	FOUGERA PHARMS INC
TACROLIMUS	TACROLIMUS	0.1%	OINTMENT;TOPICAL	Prescription	No	AB	210393	GLENMARK PHARMS LTD